Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib vs Lidocaine for Propofol Injection Pain
NCT07116304Not yet recruiting
- Sponsor
- Oman Medical Specialty Board
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
01
Overview
Randomised trial of parecoxib in Propofol injection pain (PIP), sponsored by Oman Medical Specialty Board. Primary endpoint: Incidence of pain on injection at 0 months. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
parecoxib
03
Conditions
Propofol injection pain (PIP)
Beyond the preview
Go deeper on NCT07116304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07116304.